Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00899834 · ClinicalTrials.gov registry record
DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 81
- Enrollment target
NCT00899834: Completed study, sponsored by St. Jude Children's Research Hospital.
NCT00899834 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 81 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00899834 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
Study Summary
This multi-institutional study will prospectively collect tumor and constitutional tissue samples from patients with diffuse brainstem glioma and other types of brainstem gliomas either during therapy or at autopsy to perform an extensive analysis of genetic and molecular abnormalities in these tumors.
Primary Outcome
Tissue samples will be obtained at autopsy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2006-06 |
| Est. Completion | 2015-08 |
What the finished NCT00899834 record still lists
NCT00899834 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 81 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00899834 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00899834 about?
NCT00899834 is a clinical study titled "DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma". This multi-institutional study will prospectively collect tumor and constitutional tissue samples from patients with diffuse brainstem glioma and other types of brainstem gliomas either during therapy or at autopsy to perform an extensive analysis of genetic and molecular abnormalities in these tumo...
What is the current status of trial NCT00899834?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2006-06. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT00899834?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia